Prima-CNS
- Status: aktiv; DRKS00024085
- Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly CNS lymphoma patients – a randomized phase III trial
- Kurzinformation
- Ansprechpartner:
Prof. Dr. Gerald Illerhaus (Leiter der Klinischen Prüfung)
Telefon: 0711 278-30401
E-Mail: g.illerhaus@klinikum-stuttgart.de - Studienzentrale
Telefon: 0711 278-30410, -30411, -30414
E-Mail: scc-studienzentrale@klinikum-stuttgart.de